Lipid-Based Drug Delivery Systems Market Size, Share & Trends Analysis Distribution by Type of Lipid-Based System (Liposomes, Solid Lipid Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs), Lipid Nanoparticles (LNPs), Micelles, Lipid-Polymer Hybrid Systems), Application, Route of Administration, Formulation and Segment Forecasts, 2024-2031
The Lipid-Based Drug Delivery Systems Market Size is predicted to grow with a an CAGR of 11.9% during the forecast period for 2024-2031. Lipid-based drug delivery systems (LBDDS) are intended to increase the delivery and efficacy of drugs that are poorly soluble in water. These systems employ lipids as carriers to promote drug bioavailability, resulting in greater absorption in the body. LBDDS are employed in a variety of pharmaceutical applic...
Report ID: 2764 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 180
Bioactive Formulation for Functional F&B Market, Share & Trends Analysis Report, By Ingredient Type (Prebiotics, Probiotics, Adaptogens, Polyphenols, Omega-3 Fatty Acids, Antioxidants), By Formulation Technology (Encapsulation, Microemulsions, Liposomal Delivery), By Application, By Region, and Segment Forecasts, 2024-2031
The Bioactive Formulation for Functional F&B Market is predicted to grow at an 8.31% CAGR during the forecast period for 2024-2031. Bioactive formulations in functional food and beverages (F&B) utilize biologically active compounds that provide health benefits beyond basic nutrition. These formulations typically include ingredients such as polyphenols, prebiotics, probiotics, vitamins, peptides, and dietary fibers, which are targeted at...
Report ID: 2736 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 180
Non-Sterile Outsourcing Market, Share & Trends Analysis Report, By Dosage form (Oral, Ear & Eye, Nasal, Topical, Parenteral), By Application (Human Medication, Nutraceuticals, Cosmetics, Medical Devices, Veterinary Health), By Region, and Segment Forecasts, 2024-2031
The Non-Sterile Outsourcing Market Size is valued at USD 7.50 Bn in 2023 and is predicted to reach USD 10.81 Bn by the year 2031 at an 4.8% CAGR during the forecast period for 2024-2031. A compounded medication product can be either non-sterile or sterile and contains one or more active ingredients. While it is possible to manufacture compounded sterile products internally, an alternative is to contract with a 503B outsourcing facility outside...
Report ID: 2740 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 178
GMP Biologics Market, Share & Trends Analysis Report, By Type (Monoclonal Antibodies, Polyclonal Antibody), By Application (Hospitals, Clinics, Others), By Region, and Segment Forecasts, 2024-2031
The GMP Biologics Market Size is valued at USD 52.3 Bn in 2023 and is predicted to reach USD 153.9 Bn by the year 2031 at an 14.6% CAGR during the forecast period for 2024-2031. The term "Good Manufacturing Practice" (GMP) Biologics describes the manufacture of biologic pharmaceuticals by strict legal requirements intended to guarantee the effectiveness, safety, and quality of the final product. The World Health Organization (WHO) and other or...
Report ID: 2715 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 165
Medical Device Package Validation Market Size, Share & Trends Analysis Report, By Testing Type (Physical Testing, Microbial Testing, Chemical Testing, and Visual Testing), By Device Class (Class I Devices, Class II Devices, and Class III Devices)), By Nature, By Sales Channel, By Region, Forecasts, 2024-2031
The Medical Device Package Validation Market Size is predicted to grow at a 8.61% CAGR during the forecast period for 2024-2031. The whole process of packaging validation is the identification and management of materials and production factors influencing the capacity of a packaged product to satisfy acceptance criteria. Validation's outcomes provide various advantages. Process control and assurance are attained to fulfil the device package cr...
Report ID: 2701 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 175
Hematological Malignancies Drugs Market Size, Share & Trends Analysis Report By Drugs (Monoclonal Antibodies, CAR-T Cell Therapy), By Pipeline Products, By Indication (Leukemia, Lymphoma), By Region, And Segment Forecasts, 2024-2031
The Hematological Malignancies Drugs Market Size is estimated to grow at a CAGR of 14.2% during the forecast period for 2024-2031. Hematologic malignancies are cancers that most often start in the bone marrow or the immune system cells. Lymphom, leukemia, and multiple myeloma are the three most common blood malignancies. The development of innovative agents has contributed to improved outcomes for cancer patients in recent years, re...
Report ID: 1211 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
Antibody Hit Generation and Screening Market Size, Share & Trends Analysis Distribution By Application (Cancer, Autoimmune Diseases, Infectious Diseases), Technologies (Hit Generation, Phage Display, Yeast Display, Ribosome Display, B-Cell Hybridoma Technology, Computational Tools, Screening), Antibody Type And Segment Forecasts, 2024-2031
The Antibody Hit Generation and Screening Market Size is predicted to grow at an 9.78% CAGR during the forecast period for 2024-2031. Antibody hit generation and screening is a vital step in developing therapeutic antibodies, focusing on identifying and selecting candidates that bind to a target antigen with high affinity and specificity. This process leverages various technologies like hybridoma technology, phage display, yeast display, ribos...
Report ID: 2667 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 168
Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Size, Share & Trends Analysis Report By Cloud (Private, Public, and Hybrid), Service (Infrastructure as a Service (IaaS), Platform as a Service (PaaS), and Software as a Service (SaaS)), End-Users, Region, And Segment Forecasts, 2024-2031
The Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Size is valued at 6.72 billion in 2023 and is predicted to reach 17.32 Million by the year 2031 at a 12.62% CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: Increasing adoption of advanced technologies, manual error reductions in drug development processes due to cloud-based applications, fast implem...
Report ID: 1026 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
Ovarian Cancer Market Size, Share & Trends Analysis Report By Treatment (Chemotherapy, Hormonal Therapy, Targeted Therapy, and Surgery), Region And Segment Forecasts, 2024-2031
The Ovarian Cancer Market is expected to grow at a 10.5% CAGR during the forecast period for 2024-2031. Ovarian cancer rank fifth in cancer deaths among women and accounting for more deaths than any other cancer of the female reproductive system. Previously it believed that cancer begin only in the ovaries, but recent evidence suggests that many ovarian cancer may start in the fallopian tubes. Factors can increase risk of cancer include ol...
Report ID: 1067 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
Breast Cancer Market Size, Share & Trends Analysis Report By Treatment (Chemotherapy, Hormonal Therapy, Targeted Therapy, and Surgery), Region And Segment Forecasts, 2024-2031
The Breast Cancer Market is expected to grow at an 8.8% CAGR during the forecast period for 2024-2031. Breast cancer start when cells in the breast begin to grow out of control. These cells form tumour that can often see on an x-ray. Breast cancer is the most common cancer among women, after skin cancer and second leading cause of cancer death in women after lung cancer. Breast cancer is broadly classified into two include non-invasive and...
Report ID: 1069 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 140
Pharmaceuticals